Washington [US], October 6 (ANI): Researchers at MIT and Dana-Farber Cancer Institute have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test could help doctors to choose alternative therapies for patients who don't respond to the therapies normally used to treat their cancer.
Washington [US], September 29 (ANI): Engineers have developed a technique that allows them to measure the generation rate and half-life of circulating tumour cells (CTCs) in mice.
\
\
\
\
